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Abstract
Background: A DNA vaccine expressing glycoprotein C (gC) of duck plague virus (DPV) was evaluated for inducing
immunity in ducks. The plasmid encoding gC of DPV was administered via intramuscular (IM) injection and gene
gun bombardment.
Results: After immunization by both routes virus-specific serum antibody and T-cell responses developed.
Vaccination of ducks by IM injection induced a stronger humoral, but weaker cell-mediated immune response. In
contrast, a better cell-mediated immune response was achieved by using a gene gun to deliver DNA-coated gold
beads to the epidermis with as little as 6 μg of DNA.
Conclusions: This demonstrated that both routes of DNA inoculation can be used for eliciting virus-specific
immune responses. Although DNA vaccine containing DPV gC is effective in both intramuscular injection and gene
gun bombardment, the latter could induce significantly higher cell-mediated responses against DPV.
Background
Duck plague virus (DPV), a member of the Alphaherpes-
virinae, is the causative agent of duck plague (DP), one of
most serious infectious diseases of waterfowl (duck, geese,
and swans)[1,2]. Since the first outbreak in the Nether-
lands in 1923, this disease has caused heavy economic
losses in the commercial duck industry due to mortality,
condemnations, and decreased egg production[3,4].
Vaccination is a desirable method to prevent DPV
infection. The conventional DPV vaccine are inactivated
and attenuated DPV preparations, and they have been
shown to be able to confer protection against clinical
disease[5,6]. However, as with all or most herpesvirus,
DPV has the ability to establish latent infection[7],
which adds difficulties in the control and prevention of
the transmission of DPV or the establishment of latency.
Thus, a more effective therapeutic vaccine will need to
elicit sufficient cell-mediated and humoral immune
responses.
In recent years, naked DNA encoding immunogenic
proteins of infectious agents has been introduced for
vaccination. Injection of DNA results in its uptake into
cells, expression of the gene and endogenous synthesis
of the antigen[8,9]. DNA immunization provides some
real advantages over conventional DPV vaccines, includ-
ing major histocompatibility complex (MHC) class I and
II presentation of native antigens, stability, and low pro-
duction cost[10]. Because DNA vaccination induces a
response in both the humoral and cellular arms of the
immune system, this approach offers new opportunities
in the development of vaccine.
Viral surface glycoproteins are primary targets for
immune responses and for the development of viral vac-
cines. Viral glycoprotein C is one of the several suface
glycoproteins present on the mature virus and infected
cell membrane. gC is the major target for virus-neutra-
lizing antibodies and has also been reported as the tar-
get for T-cell responses. In the cases of pseudorabies
(PRV)[11,12], herpes simplex virus type 1 (HSV-1)[13],
herpes simplex virus type 2 (HSV-2)[14] and bovine her-
pesvirus-1 (BHV-1)[15], gC has been shown to induce
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immunity and provide protection against lethal chal-
lenge following DNA immunization.
In the present study, we investigated DPV DNA vacci-
nation in ducks, the natural host of the virus. Vaccina-
tion was carried out by injecting ducks with DNA
encoding gC of DPV. We also made a comparison
between intramuscular (IM) injection and gene gun
immunization of the plasmid, and test the efficiency of
immunity induced by both routes. Here, we presented
evidence that DPV gC DNA vaccine indeed elicited
humoral and cell-mediated immune responses in ducks,
and gene gun delivery could induce a more potent cell-
mediated immune responses compared with the IM
route.
Results
ConA-induced lymphoproliferation of peripheral blood
lymphocytes (PBLs)
To analyze the proliferative response, the PBLs were iso-
lated from heparinized blood samples. Figure 1 shows
that at 3 dpi, the reaction of T lymphocytes to ConA in
PBLs of IM and gene gun immunization groups were
obviously higher than groups pcDNA3.1(+) and 0.85%
saline (P < 0.05), and achieved peak value at 5-7 dpi.
Ducks immunized via gene gun bombardment exhibited
significantly higher lymphoproliferation responses than
did those immunized intramuscularly (P < 0.05), and the
most efficient DNA immunization was achieved by
bombarding of skin with DNA-coated particles with the
dose of 6 μg plasmid. From our observations, lympho-
proliferation responses of 6 μg plasmid via gene gun
bombardment was significant higher than 3 μg and 1 μg
via the same route between 3 and 42 dpi (P < 0.05), and
was significant higher than those injected with 200 μg (5
dpi), 100 μg (between 5 and 42 dpi), and 50 μg (between
3 and 42 dpi) via IM injection (P < 0.05).
The pcDNA3.1(+) naked vector-immunized ducks did
not exhibit any detectable lymphoproliferation response
and certainly there was no lymphoproliferation activity
detected from the negative control group.
Analysis of T lymphocytes in PBLs
To determine the population of CD4+ and CD8+ T
lymphocytes in PBLs, single-cell suspensions of PBLs
were prepared following immunization and were exam-
ined by flow cytometry using antibodies against CD4
and CD8, FITC-labeled secondary antibodies, and PE,
respectively. Figure 2 shows representative data from
flow cytometric analysis stained with FITC and PE.
Since day 3, the numbers of CD4+ and CD8+ T cells
produced by either gene gun or IM injection were sig-
nificant higher when compared to results for negative
and pcDNA3.1(+) naked vector control groups (P <
0.05), and peak levels were reached between 5 and 7 dpi
(Figure 2A and 2B).
The strongest induction in CD4+ and CD8+ T cells
was observed in 6 μg plasmid via gene gun bombard-
ment at all time points analyzed. The numbers of CD4+
T cells were significant higher than 3 μg and 1 μg via
the same route between 3 and 28 dpi (P < 0.05), and
were significant higher than those injected with 200, 100
and 50 μg via IM route between 5 and 28 dpi (P <
0.05). The numbers of CD8+ T cells were significant
higher than 3 μg (between 3 and 7 dpi) and 1 μg
(between 3 and 14 dpi) via gene gun bombardment, and
were significant higher than 200 μg (7 dpi), 100 μg
(between 3 and 7 dpi) and 50 μg (between 3 and 28 dpi)
via IM injection (P < 0.05).
Figure 1 Lymphoproliferation assay. Proliferative responses were measured by MTT incorporation assessed as the OD at 570 nm. The results
represent three separate experiments (mean OD ± SD).
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A weaker induction in CD4+ and CD8+ T cells was
observed in 200 μg plasmid via IM injection. The num-
bers of CD4+ T cells were significant higher than other
DNA vaccinated groups between 3 and 28 dpi (P <
0.05). The numbers of CD8+ T cells were significant
higher than the other two IM groups between 3 and 7
dpi, and were significant higher than 3 μg (3, 5, 28 dpi)
and 1 μg (between 3 and 7 dpi) via gene gun bombard-
ment (P < 0.05).
Antibody responses induced by gene gun immunization
or IM injection of gC DNA vaccine
Serum samples were taken at indicate times after immu-
nization, and ELISA analysis showed that specific serum
IgG titers started to increase 5 days (P < 0.05) after
immunization in the DNA vaccinated groups compared
with the saline and pcDNA3.1(+) groups. As shown in
Figure 3, the serum IgG titers reached a maximum on
day 28. Both IM and gene gun groups revealed similar
pattern of antibody response. In contrast, no antibody
response was observed in the saline group.
Of IM groups, 200 μg plasmid induced the greatest
increase in titer of antibody by day 42 after immunization,
and this level returned to baseline by day 70. In contrast,
100 μg and 50 μg plasmid did not significantly increase
the titer of antibody. The antibody titer of 200 μg IM
group was significant different from 100 μg (between 3
and 42 dpi) and 50 μg (between 5 and 28 dpi) IM groups
(P < 0.05). On the other hand, of gene gun groups, 6 μg
plasmid induced a greater increase in titer of antibody, but
this effect was not significant when compared to results
for 3 μg and 1 μg gene gun groups (P > 0.05). Comparison
of serum IgG titers between IM and gene gun groups
revealed that IM injection induced an overall higher anti-
body titer than gene gun immunization, and 200 μg was
optimal for generating high antibody titers in this assay.
Figure 2 T lymphocytes in PBLs following DPV gC DNA vaccination. 3, 5, 7, 14, 28, 42 days after vaccination, the isolated PBLs were stained
with monoclonal antibodies against duck CD4 (A), and CD8 (B). The results presented are the mean of all specimens of each group ± SD.
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Induction of DPV neutralizing antibodies
Groups of 126 ducks were immunized by DPV gC DNA
vaccine, or injected with 0.85% saline, pcDNA3.1(+) and
DPV attenuated vaccine as described in materials and
methods. 3d, 5d, 7d, 14d, 28d, 42d, 70d after immuniza-
tion, sera were collected from two randomly chosen
ducks per group, and the neutralization titers were
determined using a virus neutralization test.
Ducks immunized by IM injection with pcDNA3.1(+)
had generated low but detectable levels of neutralizing
antibody, but those injected with 100 μl 0.85% saline
had no detectable neutralizing antibody responses. In
contrast, DNA vaccine immunized groups had generated
positive titers at most of the sampling times. The level
of neutralization titer in both IM and gene gun immu-
nized groups rose very rapidly since 7 dpi, reached peak
levels between 28 and 42 dpi, and then the peak levels
decreased by various rates but still had a detectable level
at the terminal of experiment (Table 1).
Discussion
Immunization of animals with naked DNA encoding
protective viral antigens promotes the induction of
humoral immune response mimicking natural infection
and cell-mediated immune response after intracellular
expression of the antigens. However, the effectiveness of
a DNA vaccine depends on several factors, such as the
selection of viral gene, the route of immunization, and
the method of vaccination.
Numerous studies have demonstrated that viral glyco-
protein C plays an important role in the induction of
antibody and T-cell response to the infection of herpes-
virus, and also the protection against lethal challenge
[16-21]. In view of such evidence, we constructed a
Figure 3 Serum IgG antibody titers obtained by ELISA assays. Ducks were immunized with the pcDNA3.1(+)/gC DNA vaccine by IM
injection or gene gun bombardment, and serum was collected at days 3, 5, 7, 14, 28, 42, and 70, as indicated. The results represent the average
of triplicate wells and are expressed as means ± SD.
Table 1 Changes of neutralizing antibody titer with different inoculation routes and different doses in ducks
Days post inoculation Serum neutralizing (SN) titera
Immune groups Control groups





DPV attenuated vaccine 100 μl 0.85% saline 100 μl
6 μg 3 μg 1 μg 200 μg 100 μg 50 μg
3 1:2.34 1:2.34 < 1:2.34 < < < < <
5 1:2.37 1:2.34 < 1:2.87 1:2.34 < < 1:3.35 <
7 1:2.82 1:2.7 1:2.34 1:3.2 1:2.58 1:2.51 < 1:5.01 <
14 1:5.62 1:3.35 1:3.4 1:4.73 1:2.87 1:2.7 1:2.34 1:6.2 <
28 1:6.3 1:4.73 1:3.2 1:6.4 1:5.01 1:4.73 1:2.34 1:5.69 <
42 1:5.69 1:4.6 1:2.82 1:6.7 1:5.56 1:3.2 < 1:4.73 <
70 1:3.4 1:2.73 < 1:3.35 1:2.37 < < 1:2.82 <
aDucks were immunized via IM or gene gun injection with DPV gC DNA vaccine. The neutralizing antibody titer represents the average of the titers from 3 serum
samples standard error. The titer in each group was expressed as the mean ± SD of all specimens in each group.
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DNA vaccine expressing gC of DPV and evaluated its
role in eliciting antibody and T-cell responses in vacci-
nated ducks.
Intramuscular and intradermal routes have been used
by many investigators. Previous experiments have sug-
gested that by direct injection, both muscle and skin
have the capacity to take up and express DNA-encoded
sequences without a special delivery system among
mammalian cells[22,23]. Although IM delivery of DNA
has been by far the most studied to date, muscle is not
considered to be a site for antigen presentation because
it contains few if any dendritic cells, macrophages, and
lymphocytes. In contrast, skin has associated lymphoid
tissue, comprising Langerhans cells, dendritic cells, kera-
tinocytes and other immune cells, which makes it highly
immunocompetent[24]. Among the several techniques
of DNA vaccine administration developed to date, gene
gun immunization has become highly popular. This
technique significantly reduces the amount of plasmid
DNA needed for immunization, which propels plasmid-
coated gold beads into the skin by pressure and achieves
the most efficient DNA immunization[25,26]. So the
present study was designed to evaluate the effect of the
route of DNA inoculation on vaccination.
Our results demonstrate that both IM and gene gun
of administration can be used for DPV gC DNA vaccine.
Gene gun delivery of DNA into the epidermis is a very
efficient method of inoculation, achieving comparable
neutralizing antibody and ELISA antibody with 8-200
times less DNA than direct inoculations of purified
DNA in saline (1-6 μg as opposed to 50-200 μg of
DNA) (Figure 3). In our tests, both routes mounted a
neutralizing antibody and ELISA antibody with high
titers in the gC DNA-immunized ducks compared with
the saline and pcDNA3.1(+) groups. We think the
remarkable success of gene gun vaccination reflects the
combination of efficient transfection with efficient anti-
gen presentation and recognition. The gene gun repre-
sents a very effective method of transfecting a tissue[27].
When the epidermis is transfected, DNA-expressed anti-
gens are subject to immune surveillance by the skin-
associated lymphoid tissue. This lymphoid tissue is rich
in cells (such as epidermal Langerhans cells) that are
capable of presenting transfected antigens to the T-
helper component of the immune system[28].
DNA immunization is thought to induce both humoral
and cell-mediated immunity, providing access of endo-
genously synthesized antigens to the MHC class I- and
class II-restricted pathways[29,30]. ConA-induced lym-
phoproliferation assays of PBLs showed that immune and
control ducks showed a non-specific response to ConA,
but the DNA-vaccinated groups raised a stronger T lym-
phocytes proliferative response. Additionally, a better
proliferative response in gene gun immunized ducks was
detected, possibly due to the more prevalency of antigen-
presenting cells (APCs) and higher transfection efficiency
in skin than muscle, suggesting that immunization by
gene gun bombardment might be a more efficient
method for the administration of our DNA construct.
It is the prevalent opinion that the inoculation of
naked plasmid DNA elicits Th cell and cytotoxic T lym-
phocyte (CTL) responses via intramuscular injection or
gene gun delivery. In humans and mice, the cellular
immune response is predominantly CD4+ and Th1-like
after HSV-2 infection[31]. CD4+ T cells are necessary to
generate a CD8+ CTL response and viral clearance after
infection with HSV[32]. CD8+ T lymphocytes limit
infection in the peripheral nervous system, maintain the
integrity of neurons during primary HSV infection[33],
and resolve HSV lesions[34]. From our present observa-
tions, both CD4+ and CD8+ T lymphocytes showed a
significant increase in the early stage after immuniza-
tion. Highest numbers of CD4+ T cells were detected at
an earlier time post infection than CD8+ T cells, and a
great increase was seen in the CD4+ T cells population,
while CD8+ T cells increased to a lesser degree in DNA
immunized ducks. The CD4+ T cell response in immu-
nized ducks is substantial and is maintained at a rela-
tively high level by the time point at the terminal of
experiment. Similar results were obtained in CD8+ T
cells. The strongest induction in CD4+ and CD8+ T
cells was observed in 6 μg plasmid via gene gun bom-
bardment at all time points analyzed. These observa-
tions, together with the results above, suggest that gene
gun immunization, i.e., bombardment of skin with
DNA-coated particles, is an efficient method for the
administration of DPV gC DNA vaccines. We also
noted that cell-mediated immune response occurred
earlier than humoral immune response, but the latter is
more long-lasting than the former, probably because
CD4+ T cells help for B cells maintain a specific anti-
body response that functions to keep this virus in check.
In summary, this investigation has indicated that vac-
cination of ducks with a DNA vaccine expressing gC of
DPV had the potential to induce antibody production
and lymphocyte proliferation, and increase the numbers
of CD4+ and CD8+ T cells in PBLs. Both of the two
routes of administration involved in this study could
raise immune responses, but gene gun bombardment
induced a more effective cell-mediate immune response
than muscle. However, further studies are needed to
identify whether the immunity, which is induced by the
vaccine, was sufficient to protect vaccinated ducks com-
pletely from DPV challenge.
Conclusions
In this work, a DNA vaccine encoding gC of DPV was
constructed and immunized ducks by IM injection and
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gene gun bombardment to determine the optimal
method of delivery for immune stimulation. Although
cell-mediated and humoral immune responses against
DPV could generate after immunization by both routes,
gene gun bombardment induced a stronger cell-
mediated immune response than muscle, suggesting that
gene gun delivery may be a more efficient method for
the administration of DPV gC DNA vaccine.
Methods
Virus and cells
Duck embryo fibroblast (DEF) cells were cultured in
minimal essential medium (MEM) (Gibco-BRL) supple-
mented with 10% fetal bovine serum (FBS) (Gibco-BRL)
at 37°C. DPV CH virulent strain was propagated on
DEF cells and subjected to titer determination.
Eukaryotic expression plasmid construction
pcDNA3.1(+)/gC was constructed by inserting the pro-
duct of gC PCR cloned from the DPV CH virulent
strain as described previously[35]. Plasmids were grown
in Escherichia coli DH5a and extracted by TIANprep
plasmid extraction kit (Tiangen, China) according to
manufacturer’s instructions. The inserted fragment was
confirmed by restriction endonuclease digestion analysis,
PCR amplification and DNA sequencing. The pcDNA3.1
(+)/gC was transfected in COS-7 cells, and gC expres-
sion in COS-7 cells was examined by indirect immuno-
fluorescence test (data not shown).
Immunization and specimen collection
This study was conducted with 126 Peking ducks (21
days old) from a DPV-free farm which were not vacci-
nated against DPV. The serum samples of all experi-
mental ducks were tested and found to be DPV
antibody negative by ELISA methods and DPV antigen
negative by PCR assay[36,37]. A total of 126 ducks were
divided into 9 groups, with 14 ducks in each group.
Routes of DNA inoculation included intramuscular and
gene gun immunization. For intramuscular injection,
200, 100 and 50 μg of DNA was administered in 100 μl
of saline. For gene gun delivery, 6, 3 and 1 μg of DNA
was administered, and with each shot, 1 μg of DNA
immobilized onto 0.5 mg gold particles was delivered at
a pressure of 300 pounds per square inch (psi) with a
Helios gene gun (Bio-Rad). Within control groups,
Group 7 was injected with 100 μg of pcDNA3.1(+),
Group 8 was vaccinated with one commercial dose of
DPV attenuated vaccine (100 μl) by intramuscular route,
and Group 9 was injected with 100 μl 0.85% saline as
negative control.
Blood samples from the jugular vein were collected at
3, 5, 7, 14, 28, 42, 70 days post inoculation (dpi). At
each of seven sampling times between 3 and 70 dpi, two
vaccinated ducks of each group were chosen randomly
for sampling.
Proliferation assays
Peripheral blood lymphocytes (PBLs) were isolated from
heparinized blood samples and resuspended at a con-
centration of 5 × 105 cells per ml in RPMI 1640 supple-
mented with 10% fetal bovine serum (FBS), 100 U/ml
penicillin, and 100 μg/ml streptomycin. Subsequently,
100 μl volumes of cell suspension were dispensed into
96-well culture plates in triplicate and the PBLs were
cultured in the absence or presence of concanavalin A
(ConA) (final concentration, 20 μg/ml). After 44 h incu-
bation with 5% CO2 at 37°C, 10 μl MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
(5 mg/ml) per well was added and incubated for another
4 h. The optical density (OD) was determined in tripli-
cate against a reagent blank at a test wavelength of 570
nm and a reference of 630 nm. The value reflected the
viable cell population in each well.
Flow cytometry
PBLs were isolated as described previously. The cells
were washed twice in PBS (0.01 M, pH7.4) and were
adjusted to a final concentration of 5 × 105 cells per ml.
Then indirect staining of the cells was carried out as fol-
lows: anti-duck CD8 monoclonal antibody and anti-duck
CD4 monoclonal antibody (AbD Serotec Ltd, UK) were
added into the cells and incubated for 30 min at 4°C in
the dark, followed by FITC-and PE-labelled goat anti-
mouse IgG (AbD Serotec Ltd, UK). Then the cells were
washed with PBS and resuspended in 500 μl PBS, and
subsequently subjected to flow cytometric analysis.
Viable lymphocytes were gated on the basis of forward
and side scatter characteristics, and 10,000 events were
analyzed for positive staining with FITC or PE. Data
analysis was carried out using BD FACSAria software.
ELISAs
Polystyrene microtitre plates were coated with 1 μg pur-
ified DPV per well. After overnight incubation at 4°C,
the plates were blocked in PBS containing 5% bovine
serum albumin (BSA) at 37°C for 2 h. After three
washes with PBS containing 0.05% Tween 20 (PBS-T),
100 μl per well of individual sera from each group was
tested with the determined optimal serum dilution.
Plates were incubated for 1 h at 37°C and washed as
aforementioned. Later, 100 μl per well of 1:3000 diluted
anti-duck horseradish peroxidase (KPL, Gaithersburg,
USA) was added and the plates were incubated for 1 h
at 37°C. After washing, 100 μl per well of 3,3’,5,5’-etra-
methylbenzidine (TMB) was added. The plates were
kept for 30 min at room temperature, and the reaction
was stopped with 100 μl per well of 2 M H2SO4. The
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OD was measured at 450 nm, using a Bio-Rad Model
860 Plate Reader (Bio-Rad, CA, USA).
Virus-neutralization assays
Sera were separated from blood samples and heat inacti-
vated at 56°C for 30 min. Serial twofold dilutions of sera
were prepared in MEM and then mixed with 100
TCID50 of DPV separately and incubated for 1 h at 37°
C. 100 μl of the above mixture was added into mono-
layer DEF cells and incubated at 37°C for 4 days. The
presence of replicating virus in the cells was scored by
cytopathic assays. Testing of each sample group
included DPV-positive and -negative sera as controls.
The virus titer of each specimen was calculated by the
Reed-Muench method[38].
Statistical analysis
The SPSS version 17.0 for Windows XP was used for
statistical analysis. Data have been presented in the text
and figures as means ± SD. Statistical analysis was done
using the one-way ANOVA test and a P value of 0.05
was considered significant.
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